Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1391-1400 of 1,460) with videos related to

Pageof 146
Sort By:
The New England Journal of Medicine|September 22, 2021
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M El Sahly, Lindsey R Baden, Brandon Essink, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
Science (New York, N.Y.)|January 30, 2025
Pre-exposure antibody prophylaxis protects macaques from severe influenzaMasaru Kanekiyo, Rebecca A Gillespie, Kristine Cooper, et al.
Science Translational Medicine|December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infectionRebecca M Lynch, Eli Boritz, Emily E Coates, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Cell Reports|October 22, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Pageof 146

Showing results (1391-1400 of 1,460) with videos related to

Sort By:
Pageof 146
The New England Journal of Medicine|September 22, 2021
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded PhaseHana M El Sahly, Lindsey R Baden, Brandon Essink, et al.
The Lancet. Infectious Diseases|August 11, 2022
Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscapeNatalie I Mazur, Jonne Terstappen, Ranju Baral, et al.
Nature|February 3, 2017
Zika virus protection by a single low-dose nucleoside-modified mRNA vaccinationNorbert Pardi, Michael J Hogan, Rebecca S Pelc, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
Science (New York, N.Y.)|January 30, 2025
Pre-exposure antibody prophylaxis protects macaques from severe influenzaMasaru Kanekiyo, Rebecca A Gillespie, Kristine Cooper, et al.
Science Translational Medicine|December 25, 2015
Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infectionRebecca M Lynch, Eli Boritz, Emily E Coates, et al.
Biorxiv : the Preprint Server for Biology|June 30, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Cell Reports|October 22, 2020
Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular ProbesTongqing Zhou, I-Ting Teng, Adam S Olia, et al.
Biorxiv : the Preprint Server for Biology|June 9, 2020
Broad sarbecovirus neutralizing antibodies define a key site of vulnerability on the SARS-CoV-2 spike proteinAnna Z Wec, Daniel Wrapp, Andrew S Herbert, et al.
Pageof 146